How long does a drug take to reach steady state?

About 4 to 5 half-lives of regular dosing. After that, concentration stops climbing and oscillates around a steady-state plateau.

What is the accumulation ratio?

R = 1 / (1 − (1/2)^(τ/t½)). When the dosing interval τ equals the half-life, R = 2: the drug accumulates to twice a single dose.

Drug half-life · steady state

Dose, decay, repeat — until the blood plateaus.

Each dose peaks then halves every half-life. Dose again before it clears and the residual stacks. Watch the curve climb to a steady-state plateau — and tip into toxicity if you crowd the schedule.

Concentration now

— mg/L

hour 0 · D0

Steady-state plateau

— mg/L

avg of final day

Accumulation ratio

—×

1 / (1 − ½^(τ/t½))

Verdict

—

over 7 days

Blood concentration Therapeutic window Toxic threshold Dose event

Common drugs

Dose interval

Parameters

Dose (mg)500

Half-life (hours)2.0

Therapeutic min (mg/L)5

Toxic threshold (mg/L)25

How to read it

Pick a drug and a dose interval (q4h = every 4 hours). The playhead sweeps left→right across 7 days; each tick mark is a dose, and the purple curve is the blood concentration it produces.

The green band is the therapeutic window — below it the drug does nothing, above the red line it turns toxic. Aim for a plateau that lives inside the band.

Why it builds to steady state

Elimination is first-order: C(t) = C₀·(½)^(t/t½). Concentration halves every half-life, no matter how high it started.

Dose again before the residual clears and the new peak stacks on what's left. After roughly 4–5 half-lives of regular dosing, intake balances elimination and the curve stops climbing — it oscillates around a steady-state plateau.

How much it accumulates is the accumulation ratio R = 1 / (1 − ½^(τ/t½)), where τ is the interval. When τ equals the half-life, R = 2: you plateau at twice a single dose's reach.

Why the schedule matters

For paracetamol (t½ ≈ 2h), labels say "every 4–6 hours" because:

q4h: peaks high, dips little — steady analgesia.
q6h: peaks lower, dips sub-therapeutic between doses.
q8h: insufficient — pain returns before the next dose.

Long-half-life drugs (loratadine, diazepam) self-stack and need only once-daily dosing. Short-half-life drugs need frequent dosing or infusion to hold a plateau.

The therapeutic window

Every drug has a band where it works without harm. Below the floor → no effect. Above the ceiling → toxicity (liver damage for paracetamol, GI bleed for ibuprofen).

Narrow-window drugs (lithium, warfarin, digoxin) demand blood-level monitoring. Wide-window OTC drugs tolerate sloppy timing.

Disclaimer

A teaching model, not medical advice. Real pharmacokinetics involves absorption rate, bioavailability, protein binding, hepatic/renal clearance, and individual variation. Thresholds here are approximations. Consult a clinician for actual dosing.

Citations

Rowland, M. & Tozer, T.N. (2010). Clinical Pharmacokinetics and Pharmacodynamics: Concepts and Applications (4th ed.). Lippincott Williams & Wilkins. Standard textbook for the one-compartment IV/PO model used here.
Shargel, L., Wu-Pong, S. & Yu, A.B.C. (2012). Applied Biopharmaceutics & Pharmacokinetics (6th ed.). McGraw-Hill. Steady-state and accumulation-ratio derivations.
FDA-approved drug labels. Paracetamol/acetaminophen (Tylenol), Ibuprofen (Advil), Caffeine USP. Hepatic clearance and half-life data from prescribing information.
Goodman & Gilman (2018). The Pharmacological Basis of Therapeutics (13th ed.). McGraw-Hill. Reference for drug-specific clearance and volume-of-distribution values.

Built by Joshua Chua · Fable rebuild · vanilla JS + Canvas